19817-07-3 Usage
Explanation
Different sources of media describe the Explanation of 19817-07-3 differently. You can refer to the following data:
1. The molecular formula represents the number of atoms of each element present in a molecule. In this case, the compound has 9 carbon (C), 13 hydrogen (H), 1 nitrogen (N), and 1 oxygen (O) atoms.
2. The compound is derived from azabicyclo[2.2.2]octane, a bicyclic compound with a nitrogen atom in the bridgehead position. An ethynyl group (-C≡CH) is added to the third carbon atom of the ring.
3. The compound has a bicyclic structure, which means it consists of two rings of carbon atoms. The azabicyclo[2.2.2]octane is a specific type of bicyclic structure with a nitrogen atom in the bridgehead position.
4. The compound contains an alcohol functional group, which is a hydroxyl group (-OH) attached to a carbon atom. It also has an ethynyl functional group, which is a carbon-carbon triple bond (-C≡CH) attached to a carbon atom.
5. The compound has potential uses in various fields, including pharmaceutical and chemical research, as well as the development of new materials and products. However, its specific properties and potential uses are still subject to further study and experimentation.
6. The compound's specific properties and potential applications are not yet fully understood and require further research and experimentation to be determined. This may include studying its chemical reactivity, stability, and potential interactions with other compounds or biological systems.
Structure
Azabicyclo[2.2.2]octane derivative with an ethynyl group at the third carbon atom
Bicyclic structure
Azabicyclo[2.2.2]octane
Functional groups
Alcohol (-OH) and ethynyl (-C≡CH)
Potential applications
Pharmaceutical and chemical research, development of new materials and products
Further study and experimentation
Required to determine specific properties and potential uses
Check Digit Verification of cas no
The CAS Registry Mumber 19817-07-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,9,8,1 and 7 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 19817-07:
(7*1)+(6*9)+(5*8)+(4*1)+(3*7)+(2*0)+(1*7)=133
133 % 10 = 3
So 19817-07-3 is a valid CAS Registry Number.
19817-07-3Relevant articles and documents
Quinuclidine chemistry: Autocondensation reactions of 3 quinuclidinone
Sandmann,McHugh Jr
, p. 890 - 891 (1977)
During the synthesis of 3-hydroxy-3-ethinylquinuclidine (I), two additional products were isolated and identified as (E)-3-[2-(3-oxoquinuclidine)]quinuclidylidene (III) and (E)-3-[2-(3-hydroxy-3-ethinylquinuclidine)]quinuclidylidene (V). The base-catalyzed auto-condensation of 3-quinuclidinone resulted in the α,β-unsaturated ketone dimer (III) as a single isomer. The geometric configuration was deduced by examination of the NMR spectra of the methyl iodide salt. Compound V was thus the result of attack on the carbonyl carbon of III by the acetylide anion. The isolation and identification of these compounds clarified the reported differences in the physical properties of I and its analogs.
Potent anti-muscarinic activity in a novel series of quinuclidine derivatives
Starck, Jean-Philippe,Talaga, Patrice,Quere, Luc,Collart, Philippe,Christophe, Bernard,Brutto, Patrick Lo,Jadot, Sophie,Chimmanamada, Dinesh,Zanda, Matteo,Wagner, Alain,Mioskowski, Charles,Massingham, Roy,Guyaux, Michel
, p. 373 - 377 (2006)
The synthesis and biological evaluation of a novel family of M3 muscarinic antagonists are described. A systematic modification of the substituents to a novel alkyne-quinuclidine scaffold yielded original compounds displaying potent in vitro an
HETEROCYCLIC COMPOUNDS FOR USE IN THE TREATMENT OF PI3K-GAMMA MEDIATED DISORDERS
-
, (2015/11/10)
Compounds and pharmaceutical compositions that modulate kinase activity, including PI3 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including PI3 kinase activity, are described herein.
1,4-DISUBSTITUTED 1,2,3-TRIAZOLES, METHODS FOR PREPARING SAME, AND DIAGNOSTIC AND THERAPEUTIC USES THEREOF
-
Paragraph 0561; 0562; 0563, (2014/02/16)
A compound having the following general formula (I): wherein: X is a nitrogen atom and Y is a carbon atom; orX is a carbon atom and Y is a nitrogen atom;the Ar group is an aryl or heteroaryl group; andthe RN and RN′ groups, together with the carbon atoms
